Daniela Lenggenhager

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Tanja Rothgangl, Melissa K. Dennis, Paulo J.C. Lin et al. · Nature Biotechnology · 2021 · 377 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands

Niels J. Rupp, Christoph A. Umbricht, Daniele Antonio Pizzuto et al. · Journal of Nuclear Medicine · 2019 · 97 citations · Full text

Medicine, Oncology, Pathology +17

Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19

Simon Bütikofer, Daniela Lenggenhager, Pedro David Wendel‐Garcia et al. · Liver International · 2021 · 93 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy

Christian Hirt, Tijmen H. Booij, Linda Grob et al. · Cell Genomics · 2022 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17